Literature DB >> 11568187

Kinetic studies of the TATA-binding protein interaction with cisplatin-modified DNA.

Y Jung1, Y Mikata, S J Lippard.   

Abstract

The TATA-binding protein (TBP) recognizes the TATA box element of transcriptional promoters and recruits other initiation factors. This essential protein binds selectively to cisplatin-damaged DNA. Electrophoretic mobility shift assays were performed to study the kinetics of TBP binding both to the TATA box and to cisplatin-damaged DNA in different sequence contexts. TBP binds with high affinity (K(d) = 0.3 nm) to DNA containing site-specific cisplatin 1,2-intrastrand d(GpG) cross-links. The k(on) and k(off) values for the formation of these TBP complexes are 1-3 x 10(5) m(-1) s(-1) and approximately 1-5 x 10(-4) s(-1), respectively, similar to the corresponding values for the formation of a TBP-TATA box complex. In electrophoretic mobility shift assay competition assays, cisplatin-damaged DNA extensively sequesters TBP from its natural binding site, the TATA box. Nine DNA probes were prepared to determine the flanking sequence dependence of TBP binding to cisplatin-modified DNA. TBP clearly displays sequence context selectivity for platinated DNA, very similar to but not as dramatic as that of the high mobility group protein HMGB1. When TBP was added to an in vitro nucleotide excision repair assay, it specifically shielded cisplatin-modified 1,2-(GpG) intrastrand cross-links from repair. These results indicate that TBP is likely to be a key protein in mediating the cytotoxicity of cisplatin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568187     DOI: 10.1074/jbc.M108299200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation.

Authors:  Gan Wang; Lynn Chuang; Xiaohong Zhang; Stephanie Colton; Alan Dombkowski; John Reiners; Amy Diakiw; Xiaoxin Susan Xu
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

2.  Transcription inhibition by platinum-DNA cross-links in live mammalian cells.

Authors:  Wee Han Ang; MyatNoeZin Myint; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

3.  Differential effects of a polyalanine tract expansion in Arx on neural development and gene expression.

Authors:  MacLean Pancoast Nasrallah; Ginam Cho; Jacqueline C Simonet; Mary E Putt; Kunio Kitamura; Jeffrey A Golden
Journal:  Hum Mol Genet       Date:  2011-11-22       Impact factor: 6.150

Review 4.  Unusual DNA binding modes for metal anticancer complexes.

Authors:  Ana M Pizarro; Peter J Sadler
Journal:  Biochimie       Date:  2009-04-01       Impact factor: 4.079

Review 5.  Inhibition of transcription by platinum antitumor compounds.

Authors:  Ryan C Todd; Stephen J Lippard
Journal:  Metallomics       Date:  2009       Impact factor: 4.526

6.  Interaction between TATA-Binding Protein (TBP) and Multiprotein Bridging Factor-1 (MBF1) from the Filamentous Insect Pathogenic Fungus Beauveria bassiana.

Authors:  Chi Song; Almudena Ortiz-Urquiza; Sheng-Hua Ying; Jin-Xia Zhang; Nemat O Keyhani
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

7.  HMGB1 bound to cisplatin-DNA adducts undergoes extensive acetylation and phosphorylation in vivo.

Authors:  Yafeng He; Yin Ding; Dan Wang; Wanjun Zhang; Weizhong Chen; Xichun Liu; Weijie Qin; Xiaohong Qian; Hao Chen; Zijian Guo
Journal:  Chem Sci       Date:  2014-12-15       Impact factor: 9.825

8.  DNA and the chromosome - varied targets for chemotherapy.

Authors:  Stephanie M Nelson; Lynnette R Ferguson; William A Denny
Journal:  Cell Chromosome       Date:  2004-05-24

Review 9.  The central role of DNA damage and repair in CAG repeat diseases.

Authors:  Thomas H Massey; Lesley Jones
Journal:  Dis Model Mech       Date:  2018-01-30       Impact factor: 5.758

Review 10.  Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity.

Authors:  Alessia Chiorazzi; Sara Semperboni; Paola Marmiroli
Journal:  Toxics       Date:  2015-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.